Rhenman & Partners Asset Management AB cut its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 56.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,000 shares of the medical instruments supplier’s stock after selling 25,000 shares during the period. Rhenman & Partners […]
Equities researchers at Redburn Atlantic began coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a report issued on Thursday, MarketBeat Ratings reports. The firm set a “buy” rating and a $235.00 price target on the medical instruments supplier’s stock. Redburn Atlantic’s price target would indicate a potential upside of 32.63% from the […]
Allianz Asset Management GmbH boosted its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 85.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 108,109 shares of the medical instruments supplier’s stock after acquiring an additional 49,715 shares during the period. […]
Infusion Pump Market to Experience Robust Growth, Reaching USD 22 6 Billion by 2032 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.